RE:Yesterday's big volume on the TSX It's almost like they've now remembered to do what they forgot to do for the past 2 years.
Having said that though it definitely feels like we are reaching a turning point. You identified the company going through a transition, with all the changes Paul is implimenting it feels almost like a re-structuring. Maybe that's over-stating things. With clarity on the R&D assets and Paul implementing his changes it feels like we are reaching the end of that process.
I'm not sure selling the re-structuring process is as easy or profitable as selling what comes out of it.
SPCEO1 wrote: I suspect the reason we saw big volume yesterday on the TSX (beating the volume on NASDAQ for the first time in recent memory) is because TH was likely speaking with analysts and portfolio managers in Canada the last couple of days and now is moving to the US via Cantor. Whenever they put out a new corporate presentation, you pretty much know they are starting an analyst/PM tour.
Given that TH has now sorted out its strategy re: cancer and NASH, an analyst/PM tour makes sense to explain that. Apparently, they got at least one or two Canadian institutions they visited with to buy, which is good. Hopefully, they have even better success in the US. And even more hopefully, they will get the Cantor analyst to pick up coverage on them. If some of Cantor's clients are intrigued by what they hear today, that will certainly increase the odds of Cantor picking up coverage, but those odds are likely still not fantastic.